```json { "scores": [ { "id": "cnv_8df91855e8334ea4", "score": 78, "tier": "great", "rationale": "Establishes dataset purpose clearly: 306 subjects, 1,191 adverse events, Xanomeline trial. Actionable context for safety monitoring." }, { "id": "cnv_73ef2a7d8f9f4dec", "score": 72, "tier": "regular", "rationale": "Comprehensive column listing with data types and meanings. Useful reference but dense; lacks synthesis of what matters most." }, { "id": "cnv_093e7749ad9e4bb2", "score": 85, "tier": "great", "rationale": "Concrete dimensions: 306×54 + 1,191×35 rows/cols, July 2012–March 2015 timespan. Essential orientation with specific numbers." }, { "id": "cnv_a909a17e64ec483a", "score": 68, "tier": "regular", "rationale": "Systematic column classification (identifiers, categorical, numeric, dates). Useful taxonomy but somewhat mechanical; low surprise." }, { "id": "cnv_4a55ffa5a7d740c3", "score": 62, "tier": "regular", "rationale": "Shows sample rows with medical coding hierarchy. Illustrative but surface-level; doesn't reveal patterns or anomalies." }, { "id": "cnv_e0902992236147dc", "score": 75, "tier": "regular", "rationale": "Zero missing values across 58 ADSL columns is reassuring. Clarifies sentinel '..MISSING..' values. Solid data-quality baseline." }, { "id": "cnv_8dd7fc41a3844fc9", "score": 58, "tier": "not_useful", "rationale": "Confirms no duplicates (expected in well-curated trial data). Low signal; doesn't guide next analytical steps." }, { "id": "cnv_097e0640d5b748b9", "score": 65, "tier": "regular", "rationale": "Distinct value counts for categorical columns. Useful for cardinality assessment but mostly confirmatory; limited actionability." }, { "id": "cnv_637cd214513341fc", "score": 48, "tier": "not_useful", "rationale": "Incomplete analysis; admits mean/median/spread not computed. Partial answer with low confidence; doesn't deliver promised insight." }, { "id": "cnv_d0dde2af6e254fc3", "score": 82, "tier": "great", "rationale": "Identifies 2 adverse events with 1977 dates (35-year anomaly), mixed severity/seriousness logic. Concrete quality issues requiring investigation." }, { "id": "cnv_0f4683eab65442c9", "score": 80, "tier": "great", "rationale": "Shows treatment arm distribution (Low 31%, Placebo 28%, High 24%, Screen Fail 17%) with planned vs. actual discrepancies. Specific, actionable." }, { "id": "cnv_b188e3302ee2494a", "score": 52, "tier": "not_useful", "rationale": "Partial answer; only reports AGE–SITEID correlation (0.192). Incomplete analysis with low confidence; doesn't reveal meaningful relationships." }, { "id": "cnv_ef9d423febc14caf", "score": 79, "tier": "great", "rationale": "Identifies treatment duration (TRTDURD) as key metric, shows max 99 days with subject details. Concrete, clinically relevant, actionable." }, { "id": "cnv_da77c68c2c044e44", "score": 81, "tier": "great", "rationale": "Three-phase temporal pattern: ramp-up (Jul 2012–Feb 2013), sustained (Mar–Nov 2013), wind-down (Dec 2013–Nov 2014). Specific, interpretable." }, { "id": "cnv_1caf6b7fa6cd49cd", "score": 77, "tier": "regular", "rationale": "Identifies peak (90 events May 2013), sharp decline mid-2014. Useful temporal landmarks but overlaps with prior insight; moderate novelty." }, { "id": "cnv_9f5c30a4c0c14181", "score": 88, "tier": "great", "rationale": "Dose-response signal: High Dose 6.23 AE/subject, Low 4.17, Placebo 3.72. Directly answers core regulatory question; highly actionable." }, { "id": "cnv_feebb7eba727457e", "score": 76, "tier": "regular", "rationale": "Maps four natural segmentation strategies (treatment arm, demographics, site, event type). Useful framework but prescriptive rather than surprising." }, { "id": "cnv_c68693d7dfd94542", "score": 55, "tier": "not_useful", "rationale": "Confirms all data is USA/NA; no real geographic variation. Clarifies dataset limitation but low signal; doesn't enable analysis." }, { "id": "cnv_00c93b96871f4309", "score": 92, "tier": "great", "rationale": "Fatal events marked non-serious while recovered events marked serious—inverts clinical hierarchy. Highly counterintuitive, demands investigation." }, { "id": "cnv_c81c3f9bfce94685", "score": 70, "tier": "regular", "rationale": "Three candidate research questions (dose-response, safety signals, discontinuation). Useful framing but generic; lacks concrete findings." } ] } ```